SCHEMBL7879829

SCHEMBL7879829

CNC(N)=NC(=O)c1cc2cccc(Oc3ccnc(N)c3)c2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 6/20 0.37
GCK P35557 3/20 0.35
FLT3 P36888 1/20 0.35
IDO1 P14902 1/20 0.35
KDR P35968 5/20 0.35
AURKA O14965 4/20 0.35
TEK Q02763 4/20 0.35
AURKB Q96GD4 4/20 0.35
LCK P06239 2/20 0.35
BRAF P15056 1/20 0.35
PTPN11 Q06124 1/20 0.34
TP53 P04637 2/20 0.34
PIM1 P11309 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
SYK P43405 1/20 0.34
ABL1 P00519 1/20 0.34
LYN P07948 1/20 0.34
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34
HRH4 Q9H3N8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7881245 0.88 IDO1 (0.39) FLT3IDO1KDRTP53SYK
SCHEMBL7879824 0.86 APEX1 (0.35) METGCKIDO1KDRAURKA
SCHEMBL7881906 0.86 CARM1 (0.36) FLT3IDO1BRAFHRH4
SCHEMBL7879703 0.86 TP53 (0.34) METGCKIDO1KDRAURKA
SCHEMBL7879954 0.85 SYK (0.36) FLT3IDO1PTPN11TP53SYK
SCHEMBL7884340 0.85 HRH4 (0.36) FLT3IDO1HRH4
SCHEMBL7878084 0.85 BRD4 (0.39) FLT3BRAFHRH4
SCHEMBL7880172 0.84 TP53 (0.35) METGCKIDO1KDRAURKA
Hydrochloric Acid SCHEMBL7880730 0.84 HRH4 (0.35) FLT3IDO1HRH4
SCHEMBL7881176 0.84 MAPK14 (0.38) METGCKKDRBRAFPTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed